Retraction Note: A novel necroptosis signature for predicting survival in lung adenocarcinoma.

IF 2.1 4区医学 Q3 GENETICS & HEREDITY BMC Medical Genomics Pub Date : 2024-10-16 DOI:10.1186/s12920-024-02030-2

Kui Zang, Min Wang, Xingxing Zhu, Bin Yao, Ying Huang

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

撤稿说明：用于预测肺腺癌存活率的新型坏死标志。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

BMC Medical Genomics 医学-遗传学

CiteScore

3.90

自引率

0.00%

发文量

243

审稿时长

3.5 months

期刊介绍： BMC Medical Genomics is an open access journal publishing original peer-reviewed research articles in all aspects of functional genomics, genome structure, genome-scale population genetics, epigenomics, proteomics, systems analysis, and pharmacogenomics in relation to human health and disease.

期刊最新文献

Genomic profiling and expanded use of targeted anticancer drugs in solid cancers with exhausted evidence-based treatment options (PRECODE): study protocol of a prospective, non-randomized, cohort study. Private detection of relatives in forensic genomics using homomorphic encryption. Elevated expression of APOO as a potential prognostic marker in breast cancer: insights from bioinformatic analysis and experimental validation. Genome-wide association analysis of cystatin c and creatinine kidney function in Chinese women. Hearing impairment and vestibular function in patients with a pathogenic splice variant in the LHX3 gene.